By Joel F. Kremer
How molecular simulation is becoming quantum computing's first defensible business advantage in life sciences, from early industrial demonstrations to a practical framework for structuring a pilot.
What You Will Learn
Instant digital delivery once payment is confirmed. Secure, time limited download link sent by email.
Related Briefings
